FDA recall D-0342-2025

Glenmark Pharmaceuticals Inc., USA · Class II · drug

Product

Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg, 100-count bottle, Rx, Only. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-562-01

Reason for recall

CGMP Deviations

Distribution

U.S. Nationwide

Key facts

Status
Ongoing
Initiation date
2025-03-13
Report date
2025-04-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Mahwah, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0342-2025